Alzheimer's Disease: Antibody Solanezumab has no Effect in the preclinical Stage

被引：0
|
作者：
Simon, Annika
机构：
来源：
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE | 2024年 / 92卷 / 07/08期
关键词：
D O I：
10.1055/a-2304-0921
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Humane monoklonale Antikorper zur Bindung verschiedener Amyloid-Formen gelten als gro ss e Hoffnung im Kampf gegen die Alzheimer-Demenz. So konnte der Antikorper Solanezumab in ersten Studien Amyloid-Monomere binden und eine gewisse neuroprotektive Funktion ubernehmen. Sperling et al. haben daher die Wirksamkeit von Solanezumab bei PatientInnen im praklinischen Stadium genauer betrachtet und
引用
收藏
页码：261 / 262
页数：2
相关论文
共 50 条
  • [31] Early-stage and preclinical Alzheimer disease
    Morris, JC
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2005, 19 (03): : 163 - 165
  • [32] Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease
    Eruysal, Emily
    Iadecola, Costantino
    Ishii, Makoto
    NEUROLOGY, 2019, 92 (15)
  • [33] Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease
    Eruysal, Emily
    Ravdin, Lisa
    Kamel, Hooman
    Iadecola, Costantino
    Ishii, Makoto
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 646 - 653
  • [34] Hypothalamic Atrophy and Third Ventricular Enlargement in the Preclinical Stage of Alzheimer's Disease
    Myslinski, Zachary
    Dyke, Jonathan
    Iadecola, Costantino
    Chiang, Gloria
    Ishii, Makoto
    ANNALS OF NEUROLOGY, 2019, 86 : S56 - S56
  • [35] Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive?
    Tayeb, Haythum O.
    Murray, Evan D.
    Price, Bruce H.
    Tarazi, Frank I.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (07) : 1075 - 1084
  • [36] Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
    Doody, Rachelle S.
    Thomas, Ronald G.
    Farlow, Martin
    Iwatsubo, Takeshi
    Vellas, Bruno
    Joffe, Steven
    Kieburtz, Karl
    Raman, Rema
    Sun, Xiaoying
    Aisen, Paul S.
    Siemers, Eric
    Liu-Seifert, Hong
    Mohs, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (04): : 311 - 321
  • [37] Preclinical predictors of Alzheimer's disease
    Albert, MS
    BRAIN AND COGNITION, 1997, 35 (03) : 284 - 285
  • [38] Preclinical prediction of Alzheimer's disease
    Albert, MS
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S561 - S561
  • [39] Preclinical Alzheimer's disease criteria
    Fagan, Anne M.
    Vos, Stephanie J. B.
    LANCET NEUROLOGY, 2013, 12 (12): : 1134 - 1134
  • [40] Characteristics of preclinical Alzheimer's disease
    Visser, PJ
    Verhey, FRJ
    Ponds, RWHM
    Jolles, J
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (01) : 88 - 89
12345